SALT LAKE CITY, Oct. 1, 2013 /PRNewswire/ -- In a move to build and enable new app management and operational capability for mission critical mobile apps, MokiMobility (www.mokimobility.com), an expert in mobile app operations, has achieved $6.6 million in additional funding today.
MokiMobility's purposed device strategy has quickly expanded to enable mission critical apps delivered through the Apple App Store or Google Play to both consumer and corporate devices. Moki's platform capabilities are implemented through a standard Software Development Kit (SDK) and cloud services available for iOS and Android devices.
The Moki platform allows you to see and manage one or thousands of installed applications to enable continuous compliance monitoring, sophisticated rule-based messaging, and remote app settings control to empower the support and operations of mission critical apps. Using Moki, enterprise administrators can identify and solve critical issues in real time.
"We have achieved our new funding due to a tremendous and growing market need for more advanced and scalable management of mission-critical mobile applications," said CEO and co-founder Tom Karren. "With nearly every business now creating 'mission critical' apps for both customers and employees, the need for full operational management of those apps has become strategic. Beyond the current model of 'app updates' and 'push messaging," we are excited to introduce software, tools and cloud services that allow app administrators to make real time changes to configurations. Moki is filing the void left by current Mobile Applications Management (MAM) solutions with actionable data and real time tools to solve problems in the field."
Karren also noted that in the months leading up to today's funding announcement MokiMobility has been acknowledged and included in the Gartner Cool Vendors in Enterprise Mobility, 2013 Report in May. Karren believes this further underscores the company's extensive work in the mobile applications arena.
The financing round includes MokiMobility's current investor, EPIC Ventures (www.epicvc.com) and includes new lead investors Pelion Venture Partners (www.pelionvp.com) and Palo-Alto-based Allegis Capital (www.allegiscapital.com) with participation from Utah-based investment team Plus550 (www.plus550.com), which includes world-class entrepreneurs and investors Rick Alden, Alan Hall, Josh James, Todd Pederson and Greg Warnock.
"As we select our investment targets, we look for talented management teams, disruptive technology and substantial markets," said Blake Modersitzki, Managing Director of Pelion Ventures. "With MokiMobility, we were fortunate to encounter all three. We are extremely pleased to lead the current round of strategic funding for this company, which is poised to lead out strongly in the growing mission critical app space."
Spencer Tall, Managing Director of Allegis Capital, "We view MokiMobility as one of the few technology companies emerging that can change the industry, by delivering a platform for the management of mobile app solutions in our consumer-oriented world. We are extremely pleased to participate in helping this company's growing suite of App Operations Management solutions move into a broader market."
MokiMobility is founded on the vision that mobile devices are increasingly the touch point where consumers and businesses interact. The company is driving and advancing the vision and delivery of advanced management for comprehensive and mission-critical apps across a variety of organizations. MokiMobility is rapidly expanding the capability and optimal operation of mobile apps and devices for business to consumer functionality where the application "just has to work."
Disclaimer: Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.